Marie-Kim St-Pierre

Marie-Kim St-Pierre

Auto-generated profile, based on publicly available information

Marie-Kim St-Pierre

Toxicology Unit, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Neurochemistry International
Verified
Journal Article
Closed access
KPKatherine Picard
Katherine Picard
MSMarie-Kim St-Pierre
Marie-Kim St-Pierre
HVHaley Vecchiarelli
Haley Vecchiarelli
MBMaude Bordeleau
Maude Bordeleau
MTMarie-Ève Tremblay
Marie-Ève Tremblay

18 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
HVHaley Vecchiarelli
Haley Vecchiarelli
KBKanchan Bisht
Kanchan Bisht
KSKaushik P Sharma
Kaushik P Sharma
SNSammy Weiser Novak
Sammy Weiser Novak
MTMarianela E. Traetta
Marianela E. Traetta
MTMarie-Ève Tremblay
Marie-Ève Tremblay
This study examined dark microglia—a state linked to central nervous system pathology and neurodegeneration—during postnatal development in the mouse ventral hippocampus, finding that dark microglia interact with blood vessels and synapses and perform trogocytosis of pre-synaptic axon terminals. Furthermore, we found that dark microglia in development notably expressed C-type lectin domain family 7 member A (CLEC7a), lipoprotein lipase (LPL) and triggering receptor expressed on myeloid cells 2 (TREM2) and required TREM2, differently from other microglia, suggesting a link between their role in remodeling during development and central nervous system pathology. Together, these results point towards a previously under-appreciated role for dark microglia in synaptic pruning and plasticity during normal postnatal development.

4 August 2026 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
RMRafael Medina-Guzmán
Rafael Medina-Guzmán
BBBazhena Bahatyrevich
Bazhena Bahatyrevich
MSMarie-Kim St-Pierre
Marie-Kim St-Pierre
SMSara Márquez-Pérez
Sara Márquez-Pérez
EGELENA GAVILÁN
ELENA GAVILÁN
MBMiguel Angel Burguillos
Miguel Angel Burguillos
Caspase-3, a cysteine-aspartic protease canonically known for its role in apoptotic cell death, has been implicated in several non-apoptotic functions, particularly in microglia, the brain-resident macrophages. These novel functions appear to depend on distinct levels of caspase-3 activation; however, the role of basal caspase-3 activity remains unclear. Here, we show that basal caspase-3 regulates RNA splicing in microglia, and its deficiency in a Parkinson´s disease (PD) model leads to splicing dysregulation. Loss of basal caspase-3 activity also increases double-stranded RNA (dsRNA) accumulation, inducing a type I interferon response. Additionally, caspase-3 deficiency impairs mitochondrial respiration, reduces ATP production, and causes sex-specific mitochondrial abnormalities, predominantly in female microglia. Together, our findings uncover a non-apoptotic, homeostatic role for basal caspase-3 activity in microglia. Its disruption, such as in PD, may drive key molecular features of neuroinflammation and neurodegeneration, positioning caspase-3 as a critical regulator of microglial function in health and disease.

18 March 2026 in Cell Death & Differentiation
Verified
Journal Article
Open access
MCMathilde Cheray
Mathilde Cheray
MPMercedes Posada-Pérez
Mercedes Posada-Pérez
AFAdamantia Fragopoulou
Adamantia Fragopoulou
CRCarlos F. D. Rodrigues
Carlos F. D. Rodrigues
AMAdriana-Natalia Murgoci
Adriana-Natalia Murgoci
BJBertrand Joseph
Bertrand Joseph
Glioblastoma, IDH1 wildtype, aggressive primary brain tumors with a dismal prognosis, promote the recruitment of microglia, brain resident innate immune cells, and ultimately their activation toward a tumor-supportive phenotype that increases gliomal proliferation and invasion capability. Here, we report that upon stimulation by glioma cells, microglia transit via a reactive state holding anti-tumoral properties coupled to reduced DNA methyltransferase 3 A (DNMT3A) chromatin occupancy and DNA demethylation that promote the expression of gene sets related to the transforming growth factor beta (TGF-β)-dependent microglial homeostasis and the microglial sensome. We find that upon repression of Dnmt3a expression in microglia, those cells maintain anti-tumoral attributes in vitro and in vivo. In a syngeneic immunocompetent glioblastoma mouse model, brain delivery of antisense oligonucleotide targeting Dnmt3a expression led to microglial activation and reduced tumor growth. Taken together, our results reveal the involvement of DNA demethylation in the control of glioma cells-induced microglia activation and indicate that microglial DNMT3A is a potentially therapeutic target to treat brain neoplasms such as glioblastoma that include a microglial component.